Wellington Partners
Life Sciences
A leading European Venture Capital firm investing in early- and growth-stage Life Science companies.
Focus
Therapeutics, Medtech, Diagnostics, Digital Health and Biotechnology.
Strong entrepreneurial teams, deep domain knowledge.
Disruptive, innovative tech addressing high unmet medical needs in attractive markets.
Scope
Europe, special circumstances US, leader in Germany.
Seed to late-stage, private companies most of the time.
Ticket sizes from €1m up to €10m over life of investment.
Funds
Managing and investing out of funds WP III and WP IV.
More than €200m AUM dedicated to Life Sciences.
Investment Team with strong clinical, scientific and operational backgrounds.